Advertisement

Topics

Evotec to acquire Aptuit for $300m

19:00 EDT 30 Jul 2017 | Pharmaceutical Business Review

German small molecule drugs developer Evotec has agreed to acquire pharmaceutical services company Aptuit for $300m from private equity firm Welsh, Carson, Anderson & Stowe (WCAS).

Original Article: Evotec to acquire Aptuit for $300m

NEXT ARTICLE

More From BioPortfolio on "Evotec to acquire Aptuit for $300m"

Quick Search
Advertisement